What are the Challenges in Implementing NGS for Vaccine Development?
1. Data Analysis: The sheer volume of data generated by NGS requires sophisticated bioinformatics tools and expertise to analyze. 2. Cost: Initial setup and operational costs can be prohibitive for smaller research labs. 3. Regulatory Hurdles: Ensuring that NGS-based findings meet regulatory standards for vaccine approval can be challenging. 4. Technical Expertise: Requires specialized knowledge in genomics and bioinformatics.
